Affiliations 

  • 1 Division of Infection Biology and Medical Microbiology, Department of Life Sciences (DLS), School of Basic and Applied Sciences, Central University of Tamil Nadu (CUTN), Thiruvarur, Tamilnadu, 610 005, India. shankarem@cutn.ac.in
  • 2 Laboratory-Based Department, Universiti Kuala Lumpur Royal College of Medicine Perak (UniKL-RCMP), Ipoh, Malaysia
  • 3 Central University of Tamil Nadu (CUTN), Thiruvarur, Tamilnadu, 610 005, India
Med Microbiol Immunol, 2018 Aug;207(3-4):167-174.
PMID: 29936565 DOI: 10.1007/s00430-018-0547-0

Abstract

T-cell exhaustion reportedly leads to dysfunctional immune responses of antigen-specific T cells. Investigations have revealed that T cells expand into functionally defective phenotypes with poor recall/memory abilities to parasitic antigens. The exploitation of co-inhibitory pathways represent a highly viable area of translational research that has very well been utilized against certain cancerous conditions. Malaria, at times, evolve into a sustained chronic state where T cells express several co-inhibitory molecules (negative immune checkpoints) facilitating parasite escape and sub-optimal protective responses. Experimental evidence suggests that blockade of co-inhibitory molecules on T cells in malaria could result in the sustenance of protective responses together with dramatic parasite clearance. The role of several co-inhibitory molecules in malaria infection largely remain unclear, and here we discussed the potential applicability of co-inhibitory molecules in the management of malaria with a view to harness protective host responses against chronic disease and associated consequences.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.